Mach7 Technologies Limited (ASX:M7T)

Australia flag Australia · Delayed Price · Currency is AUD
0.3200
0.00 (0.00%)
Jun 5, 2026, 4:10 PM AEST
Market Cap75.20M -15.2%
Revenue (ttm)29.70M -11.4%
Net Income-10.08M
EPS-0.04
Shares Out 235.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume393,377
Open0.3200
Previous Close0.3200
Day's Range0.3200 - 0.3300
52-Week Range0.2450 - 0.6850
Beta0.96
AnalystsBuy
Price Target0.35 (+9.38%)
Earnings DateApr 24, 2026

About Mach7 Technologies

Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients’ medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images ... [Read more]

Sector Healthcare
Founded 2007
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol M7T
Full Company Profile

Financial Performance

In fiscal year 2025, Mach7 Technologies's revenue was 33.79 million, an increase of 16.00% compared to the previous year's 29.13 million. Losses were -6.20 million, -22.19% less than in 2024.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for M7T stock is "Buy." The 12-month stock price target is $0.35, which is an increase of 9.38% from the latest price.

Price Target
$0.35
(9.38% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Mach7 Technologies to Showcase Enterprise Imaging Innovation and New eUnity Digital Pathology Capabilities at SIIM26

Company to highlight enterprise imaging workflows, enterprise viewing, and digital pathology capabilities at Booth 608 BURLINGTON, Vt., June 1, 2026 /PRNewswire/ -- Mach7 Technologies (ASX:M7T), a pro...

6 days ago - PRNewsWire

Mach7 Technologies CFO Steps Down; VP Shawni Hadfield Takes Interim Role

(RTTNews) - Healthcare Software firm Mach7 Technologies Limited (M7T.AX) announced Monday that Daniel Lee has resigned as Chief Financial Officer to focus on family priorities.

4 weeks ago - Nasdaq

Mach7 Technologies Earnings Call Transcript: Q3 2026

Q3 saw improved financial discipline, with ARR up 2% and positive cash flow. FY26 revenue is expected to dip 15% due to delayed capital deals, but recurring revenue and pipeline growth remain strong. Strategic reset, cost control, and AI-driven innovation are driving future growth.

6 weeks ago - Transcripts

Mach7 Technologies Slides: Q3 2026

Mach7 Technologies has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on April 23, 2026.

6 weeks ago - Filings

Mach7 Technologies Earnings release: Q3 2026

Mach7 Technologies released its Q3 2026 earnings on April 23, 2026, summarizing the period's financial results.

6 weeks ago - Filings

Mach7 Technologies Earnings Call Transcript: H1 2026

Completed a comprehensive reset, resulting in lower revenue but strong recurring income and gross margins. Strategic investments in modular Flamingo solutions and operational discipline position the company for growth in FY27, with a robust balance sheet and expanding market opportunities.

3 months ago - Transcripts

Mach7 Technologies Quarterly report: H1 2026

Mach7 Technologies has published its H1 2026 quarterly earnings report on February 26, 2026.

3 months ago - Filings

Mach7 Technologies Slides: H1 2026

Mach7 Technologies has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 26, 2026.

3 months ago - Filings

Mach7 Technologies Earnings release: H1 2026

Mach7 Technologies released its H1 2026 earnings on February 26, 2026, summarizing the period's financial results.

3 months ago - Filings

Q2 2026 Mach7 Technologies Ltd Activities Report Presentation Transcript

Q2 2026 Mach7 Technologies Ltd Activities Report Presentation Transcript

4 months ago - GuruFocus

Mach7 Technologies Earnings Call Transcript: Q2 2026

Q2 FY26 saw stable ARR, improved cash flow, and disciplined cost management, with new product launches and strategic focus on Asia and the Middle East. Flamingo is expected to drive growth in H2 FY26 and FY27, though full impact will take time to materialize.

4 months ago - Transcripts

Mach7 Technologies Earnings release: Q2 2026

Mach7 Technologies released its Q2 2026 earnings on January 29, 2026, summarizing the period's financial results.

4 months ago - Filings

Mach7 Technologies Transcript: AGM 2025

The meeting reviewed strong FY 2025 financials, a successful CEO transition, and a major strategic reset focused on AI-driven imaging, operational efficiency, and global expansion. All resolutions were presented with no questions raised, and the company is positioned for growth in FY 2027 and beyond.

6 months ago - Transcripts

Mach7 Technologies Slides: FY 2025

Mach7 Technologies has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 27, 2025.

6 months ago - Filings

Mach7 Technologies Launches New Flight Path for Medical Imaging - "from Archive to Architecture" at RSNA 2025

Mach7 soars at RSNA 2025 with an entirely new image built for speed, balance, and freedom. SOUTH BURLINGTON, Vt.

7 months ago - PRNewsWire

Mach7 Technologies Slides: Investor Presentation

Mach7 Technologies has posted slides in relation to its latest quarterly earnings report, which was published on November 17, 2025.

7 months ago - Filings

Mach7 Technologies Earnings Call Transcript: Q1 2026

First quarter marked by a strategic reset, new leadership, and operational restructuring. Recurring revenue and sales orders grew, while staff costs and total payments declined. Focus remains on disciplined execution, innovation, and customer-centric transformation.

7 months ago - Transcripts

Mach7 Technologies Earnings release: Q1 2026

Mach7 Technologies released its Q1 2026 earnings on October 30, 2025, summarizing the period's financial results.

7 months ago - Filings

Mach7 Technologies Slides: Q1 2026

Mach7 Technologies has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on October 30, 2025.

7 months ago - Filings

Mach7 Technologies Earnings Call Transcript: H2 2025

Revenue grew 16% year-over-year with recurring revenue now 75% of total, driving improved profitability and a strong cash position. A new customer engagement model has led to higher satisfaction, and a strategic review is underway to refine focus and guidance.

10 months ago - Transcripts

Mach7 Technologies Annual report: H2 2025

Mach7 Technologies has published its H2 2025 annual report on August 26, 2025.

10 months ago - Filings

Mach7 Technologies Slides: H2 2025

Mach7 Technologies has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 26, 2025.

10 months ago - Filings

Mach7 Technologies Earnings release: H2 2025

Mach7 Technologies released its H2 2025 earnings on August 26, 2025, summarizing the period's financial results.

10 months ago - Filings

Mach7 Technologies Earnings Call Transcript: Q4 2025

Q4 FY25 saw strong cash flow, $30.2M CAR, and $23.5M ARR, with a customer-centric strategy overhaul and leadership changes. Focus is on profitable growth, improved customer engagement, and targeted R&D, with optimism for key contract renewals and the VA program going live.

11 months ago - Transcripts

Mach7 Technologies Earnings release: Q4 2025

Mach7 Technologies released its Q4 2025 earnings on July 28, 2025, summarizing the period's financial results.

11 months ago - Filings